When every week of delay costs $600,000, legacy vendors’ 16+ week deployments aren’t just slow, they’re expensive. We deliver modern hybrid studies in 4-8 weeks
One platform, not five vendors. Built for how trials actually run.
Direct-to-patient studies without the typical vendor chaos. Integrated eConsent, ePRO, and automated medical record retrieval. Learn about RWE for FDA submissions.
eConsent + eCOA + EDC in one platform. Not three vendors, three contracts, and integration nightmares. Built for hybrid trials from day one.
Complex branching logic that actually works. Offline capability. SMS backup. In 20+ languages. Sites love our eCOA platform because patients actually use it.
Castor Catalyst automates EMR data extraction and processing. Reduces chart review from 30 to 6 minutes. AI processes medical records with human validation. Cuts study costs by 80% and data errors by 14%.
After 15 years in this industry, you know every vendor claims they’re different. We use innovation like Castor Catalyst AI and integrated eConsent to actually reduce site and patient burden—not just talk about it. No revolution. No transformation. Just better tools that make trials run smoother.
Not “fast.” Not “industry-leading.” Actual weeks.
Phase I dose escalation
Small RWE studies
Standard safety studies
eConsent + eCOA + EDC
Multi-site with home visits
Direct-to-patient registries
Phase III multi-region
Complex eCOA licensing
10+ languages
Reality check: Add 2-3 weeks if your protocol is still changing. Add 2-4 weeks for complex integrations. All translations delivered concurrently using AI with human supervision—no sequential delays. We’ll tell you upfront.
Deep expertise across complex indications with purpose-built workflows.
Complex protocols, longitudinal PROs, safety monitoring. Average 40% faster patient enrollment with integrated eCOA.
Depression, pain, addiction scales. Validated instruments in 40+ languages. Real-time AE monitoring.
Small populations, genetic studies, patient registries. Direct-to-patient capabilities reduce site burden by 60%.
Asthma, COPD, allergic rhinitis trials. Validated symptom diaries, peak flow integration, medication tracking. 90%+ diary completion rates.
Vaccine trials, symptom tracking, outbreak studies. Rapid deployment in 2-4 weeks for emergency protocols. See our WHO COVID trial success.
Heart failure QoL, activity monitoring, medication adherence. Integrated device data capture from wearables.
Need a platform built for your therapeutic area’s unique challenges?
Here’s what actually happens when you need help.
Continuous monitoring with PagerDuty alerts. We know about issues before you do. Critical system events wake our engineers instantly.
24/7 phone support with direct engineer escalation. Average response time: 15 minutes for critical issues affecting your trial.
CSAT Score
87% First-Call Resolution
Castor is ISO 27001 certified and compliant with 21 CFR Part 11, GDPR, HIPAA, and GCP. Built for security, our platform has been successfully audited by global sponsors. Learn more about our GCP compliance.
Separate eCOA and EDC databases mean manual reconciliation nightmares. Castor’s unified platform means one source of truth, real-time data flow, zero reconciliation.
Your data, available 24/7 in CDISC formats. Full export documentation. No hostage situations. Complete data portability with our EDC system.
Seamless integration with CTMS, IWRS, and other systems via standardized APIs. Built for CRO and sponsor workflows with transparent timelines and minimal disruption.
Waiting days for data exports kills decision-making. Our open APIs provide instant access to your trial data. Full documentation at data.castoredc.com/api.
Talk to our clinical experts who understand your challenges.
Castor’s RESTful API is built on OAuth2 and designed for secure, scalable integration with external systems. You can find our full API documentation with details on authentication, endpoints and rate limits here.
Castor Catalyst automates source data extraction from EHRs and other records, reducing time spent on manual data entry and source data verification by up to 80%. AI-driven processing with clinical expert validation enables real-time data mapping, eliminates manual SDV, and improves data quality while accelerating outputs.
Castor can deploy eCOA in 4–6 weeks for standard studies and 6–8 weeks for complex designs. Our eCOA instrument library enables reuse of validated instruments across sponsors, accelerating setup times. Timelines are managed by a dedicated implementation team and tracked in a shared project plan from kickoff through UAT.
Castor provides a dedicated Project Manager and Clinical Implementation Specialist to lead the end-to-end design, build, and deployment of each study. Support includes UAT coordination, custom or self-guided training via Castor Academy, and go-live assistance. Our support team maintains a 5.0/5 CSAT score with 87% first-call resolution and offers a structured hypercare period post-launch to ensure a smooth transition.
Yes, Castor fully supports hybrid and decentralized trials through a unified platform that integrates eConsent, eCOA/ePRO & EDC. Sponsors can deploy configurable recruitment portals, prescreeners, and hybrid data capture workflows without relying on separate systems. This approach accelerates enrollment by up to 40% and streamlines study participation through real-time, patient-driven data capture workflows.
Castor has supported over 450 biopharma studies, including global Phase III trials, and is trusted by the top 20 pharma companies. Our strong foundation in Electronic Data Capture (EDC) and integrated ePRO/eCOA platform enable us to support complex protocols and multi-region deployments. Notably, we supported the WHO Solidarity trial, enrolling over 15,000 participants across 600 sites in 52 countries, where fast, user-friendly data capture was critical.
Castor’s eCOA platform currently supports over 20 languages and can be translated into any language as needed. Translations are delivered to avoid delays, with full linguistic validation available as need. Additional languages can be added on request.
Castor supports integration with CTMS, IWRS, and other systems through a secure, well-documented RESTful API that enables two-way data exchange. We have experience delivering integrations with EDC, CTMS, IWRS and other vendor systems, and our dedicated integrations team collaborates closely with sponsors to support integration efforts as needed.
Castor supports global regulatory requirements out of the box, including compliance with FDA guidelines (21 CFR Part 11), EMA guidelines, GDPR, and HIPAA. The platform includes full audit trails, electronic signatures, and regional data hosting options to meet local data protection and privacy laws.
Castor is ISO 27001 certified and fully compliant with 21 CFR Part 11, GDPR, HIPAA, and other relevant global regulatory standards. Our platform is built with data security at its core and has been successfully audited by global enterprise sponsors.
Oncology, CNS, Rare Disease, Respiratory & Allergy, Infectious Disease, and Cardiovascular.
Castor delivers >99.9% uptime, backed by continuous monitoring, automatic failover, and high-availability architecture across multiple Azure availability zones. System status and incident updates are publicly available at castorstatus.com. On-call engineers are alerted 24/7 via PagerDuty for immediate response to critical issues.
Castor CDMS manages protocol amendments and post-production changes using our FormSync feature, which syncs validated eCRF updates from a linked test environment to the live study. This ensures study teams can test and validate eCRF updates before deployment; minimizing disruption to ongoing data collection.
Castor ensures data security and privacy through end-to-end encryption, ISO27001 & SOC 2 Type II certified infrastructure, and compliance with GDPR, HIPAA, and 21 CFR Part 11. We’ve implemented role-based access controls, audit trails, and regional data hosting, supported by bi-annual penetration testing. Our applications follow OWASP Top 10 principles and are continuously assessed for vulnerabilities. For a detailed overview of our security practices, visit our full Security Statement.